Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Low-Dose Versus Standard-Dose Alteplase for Intravenous Thrombolysis in Patients With Acute Ischemic Stroke in Iran: Results From the Safe Implementation of Treatments in Stroke Registry Publisher



Sadeghihokmabadi E1 ; Ghoreishi A2 ; Rikhtegar R3 ; Sariaslani P4 ; Rafie S5 ; Vakilian A6, 7 ; Sharifipour E8 ; Mehrpour M9 ; Saadatnia M10 ; Mirzaaghazadehattari M11 ; Farhoudi M1
Authors

Source: Current Journal of Neurology Published:2021


Abstract

Background: Rates of intracranial hemorrhage (ICH) after intravenous thrombolysis (IVT) differ depending on ethnicity, one reason that few Eastern countries have approved a lower dose of alteplase. Data in this regard are scarce in the Middle Eastern region. Methods: The present retrospective study was performed on data extracted from the Safe Implementation of Treatments in Stroke (SITS) registry. Computed tomography (CT) image analysis was based on the SITS-Monitoring Study (SITS-MOST) definition for symptomatic ICH (SICH). Functional outcome at 3 months was assessed using the modified Rankin Scale (mRS). Multivariate logistic regression including adjusted analysis was used for comparison between groups. Results: Of 6615 patients, 1055 were enrolled. A total of 86% (n = 906) received a standard dose and 14% (n = 149) received a low dose of alteplase. Favorable 3-month outcome was achieved in 481 (53%) patients in the standard group and 71 (48%) patients in the low-dose group [adjusted odds ratio (AOR) = 1.24, 95% confidence interval (CI): 0.87-1.75, P = 0.218]. SICH occurred in 14 (1.5%) patients in the standard group and 3 (2%) patients in the low-dose group [odds ratio (OR) = 2.77, 95% CI: 0.36-21.04, P = 0.120]. At 3 months, mortality occurred in 145 (16.0%) patients in the standard group and 29 (19.4%) patients in the low-dose group (OR = 1.22, 95% CI: 0.78-1.91, P = 0.346). Conclusion: Low-dose compared to standard-dose alteplase for patients with acute ischemic stroke (AIS) was not associated with fewer hemorrhagic events and there was no significant difference in the favorable 3-month outcome (mRS: 0-2) or mortality rate. © 2021 Iranian Neurological Association, and Tehran University of Medical Sciences.
Related Docs
View other Related Docs
1. Dose Optimization Study for Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke: A Study From Middle-East, Neurology Asia (2021)
2. Intracranial Hemorrhage in Normotensive and Hypertensive Patients Receiving Streptokinase After Decreasing Elevated Blood Pressure, Journal of Research in Medical Sciences (2005)
3. Optimizing Acute Ischemic Stroke Outcomes: The Role of Tenecteplase Before Mechanical Thrombectomy, Clinical Therapeutics (2024)
Experts (# of related papers)
View all Related Experts
Mohammad Saadatnia (4)
Nizal Sarrafzadegan (3)
Other Related Docs
4. Distribution by Location of Ct-Diagnosed Primary Intracerebral Hemorrhage in Isfahan, Journal of Research in Medical Sciences (2005)
5. Safety of Current Therapies for Cardiogenic Cerebral Embolism: A Systematic Review, Journal of Endovascular Resuscitation and Trauma Management (2025)
6. Neuroprotective Effects of Erythropoietin in Acute Ischemic Stroke, International Journal of Preventive Medicine (2013)
7. The Role of Imaging in Predicting 3-Month Prognosis of Primary Intracerebral Hemorrhage: A Single-Center, Prospective Observational Study in Tertiary Care Hospital, Quantitative Imaging in Medicine and Surgery (2025)
8. A Multicenter Diagnostic Accuracy Study on Prehospital Stroke Screening Scales, Archives of Iranian Medicine (2021)
9. Barthel Index in a Middle-East Country: Translation, Validity and Reliability, Cerebrovascular Diseases (2006)
10. The Frequency of Recurrence in Primary Hypertensive Intracerebral Hemorrhage, Journal of Research in Medical Sciences (2006)
11. Evaluation of Rivaroxaban Versus Warfarin for the Treatment of Cerebral Vein Thrombosis: A Case-Control Blinded Study, Current Journal of Neurology (2021)
12. Temporal Trends of Stroke Incidence Over 14 Years in Iran: Findings of a Large-Scale Multi-Centric Hospital-Based Registry, Neurology Asia (2023)
13. A Promising Method of Enhancement for Early Detection of Ischemic Stroke, Journal of Research in Medical Sciences (2012)
14. Different Stroke Scales; Which Scale or Scales Should Be Used?, Caspian Journal of Internal Medicine (2021)
15. Enoxaparin Initiation After Chronic Subdural Haematoma Evacuation: A Randomized Clinical Trial on Timing and Outcomes, Surgical Practice (2023)
16. Half-Saline Versus Normal-Saline As Irrigation Solutions in Burr Hole Craniostomy to Treat Chronic Subdural Hematomata: A Randomized Clinical Trial, Korean Journal of Neurotrauma (2022)
17. Comparison of Changes in Serum Fibrinogen Level in Primary Intracranial Hemorrhage (Ich) and Ischemic Stroke, ARYA Atherosclerosis (2012)
18. Epidemiologic Evaluation of Stroke Risk Factors Among Rural-Urban Patients in Isfahan University Hospitals, Iran, Journal of Isfahan Medical School (2012)
19. Effect of Decompressive Hemicraniectomy on Mortality of Malignant Middle Cerebral Artery Infarction, Journal of Research in Medical Sciences (2010)
20. One-Year Survival and Prognostic Factors for Survival Among Stroke Patients: The Prove-Stroke Study, Journal of Research in Medical Sciences (2022)